Showing results (1261-1270 of 1,461) with videos related to

Sort By:
Pageof 147
Cancers|December 10, 2021
Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse GliomasGuangyang Yu, Ying Pang, Mythili Merchant, et al.
Human Molecular Genetics|July 1, 1996
Evidence for locus heterogeneity in the Bethlem myopathy and linkage to 2q37M C Speer, R Tandan, P N Rao, et al.
Neuro-Oncology Practice|December 14, 2019
The association between BMI and BSA-temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525H Ian Robins, Jens Eickhoff, Mark R Gilbert, et al.
The Lancet. Oncology|November 8, 2015
Immunotherapy response assessment in neuro-oncology: a report of the RANO working groupHideho Okada, Michael Weller, Raymond Huang, et al.
Neuro-Oncology Advances|February 23, 2023
Discovery of clinical and demographic determinants of symptom burden in primary brain tumor patients using network analysis and unsupervised clusteringBrandon H Bergsneider, Elizabeth Vera, Ophir Gal, et al.
Neuro-Oncology Practice|February 7, 2025
The COVID-19 pandemic experience for patients with central nervous system tumors: Differences in patient-reported outcomes and practice recommendationsAmanda L King, Kayla N Roche, Elizabeth Vera, et al.
Molecular Autism|July 18, 2015
Targeted massively parallel sequencing of autism spectrum disorder-associated genes in a case control cohort reveals rare loss-of-function risk variantsAnthony J Griswold, Nicole D Dueker, Derek Van Booven, et al.
Journal of Alzheimer'S Disease & Parkinsonism|November 28, 2017
Exome Sequencing of Extended Families with Alzheimer's Disease Identifies Novel Genes Implicated in Cell Immunity and Neuronal FunctionH N Cukier, B K Kunkle, K L Hamilton, et al.
Autism Research : Official Journal of the International Society for Autism Research|October 12, 2012
The expanding role of MBD genes in autism: identification of a MECP2 duplication and novel alterations in MBD5, MBD6, and SETDB1Holly N Cukier, Joycelyn M Lee, Deqiong Ma, et al.
Cancer & Metabolism|October 26, 2020
Metabolic plasticity of IDH1-mutant glioma cell lines is responsible for low sensitivity to glutaminase inhibitionVictor Ruiz-Rodado, Adrian Lita, Tyrone Dowdy, et al.
Pageof 147